Evidence map›Paper›PMID 31944172›Full record

ArticleAutophagy2020

Metabolic effects of RUBCN/Rubicon deficiency in kidney proximal tubular epithelial cells.

Jun Matsuda, Atsushi Takahashi, Yoshitsugu Takabatake, Shinsuke Sakai, Satoshi Minami, Takeshi Yamamoto, Ryuta Fujimura, Tomoko Namba-Hamano, Hiroaki Yonishi, Jun Nakamura and 12 more

Abstract read
In one paragraph

Article in Autophagy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Rubicon modulates neuroimmune responses following traumatic brain injury.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. MondoA and AKI and AKI-to-CKD Transition.Journal of the American Society of Nephrology : JASN · 2024
    Article
  16. Article
  17. Lipid Droplet-Mitochondria Contacts in Health and Disease.International journal of molecular sciences · 2024
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Jun MatsudaDepartment of Nephrology, Osaka University Graduate School of Medicine , Osaka, Japan.
Atsushi TakahashiDepartment of Nephrology, Osaka University Graduate School of Medicine , Osaka, Japan.
Yoshitsugu TakabatakeDepartment of Nephrology, Osaka University Graduate School of Medicine , Osaka, Japan.ORCID 0000-0002-8912-2316
Shinsuke SakaiDepartment of Nephrology, Osaka University Graduate School of Medicine , Osaka, Japan.
Satoshi MinamiDepartment of Nephrology, Osaka University Graduate School of Medicine , Osaka, Japan.
Takeshi YamamotoDepartment of Nephrology, Osaka University Graduate School of Medicine , Osaka, Japan.
Ryuta FujimuraDepartment of Nephrology, Osaka University Graduate School of Medicine , Osaka, Japan.
Tomoko Namba-HamanoDepartment of Nephrology, Osaka University Graduate School of Medicine , Osaka, Japan.ORCID 0000-0002-6049-7616
Hiroaki YonishiDepartment of Nephrology, Osaka University Graduate School of Medicine , Osaka, Japan.
Jun NakamuraDepartment of Nephrology, Osaka University Graduate School of Medicine , Osaka, Japan.
Tomonori KimuraDepartment of Nephrology, Osaka University Graduate School of Medicine , Osaka, Japan.
Jun-Ya KaimoriDepartment of Advanced Technology for Transplantation, Osaka University Graduate School of Medicine , Osaka, Japan.
Isao MatsuiDepartment of Nephrology, Osaka University Graduate School of Medicine , Osaka, Japan.ORCID 0000-0001-8378-6130
Masatomo TakahashiDivision of Metabolomics, Medical Institute of Bioregulation, Kyushu University , Fukuoka, Japan.
Motonao NakaoDivision of Metabolomics, Medical Institute of Bioregulation, Kyushu University , Fukuoka, Japan.
Yoshihiro IzumiDivision of Metabolomics, Medical Institute of Bioregulation, Kyushu University , Fukuoka, Japan.
Takeshi BambaDivision of Metabolomics, Medical Institute of Bioregulation, Kyushu University , Fukuoka, Japan.
Taiji MatsusakaInstitute of Medical Science and Department of Basic Sciences, Tokai University School of Medicine , Isehara, Japan.
Fumio NiimuraDepartment of Pediatrics, Tokai University School of Medicine , Isehara, Japan.
Motoko YanagitaDepartment of Nephrology, Kyoto University Graduate School of Medicine , Kyoto, Japan.
Tamotsu YoshimoriDepartment of Genetics, Osaka University Graduate School of Medicine , Osaka, Japan.
Yoshitaka IsakaDepartment of Nephrology, Osaka University Graduate School of Medicine , Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macroautophagy/autophagy is a lysosomal degradation system which plays a protective role against kidney injury. RUBCN/Rubicon (RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein) inhibits the fusion of autophagosomes and lysosomes. However, its physiological role in kidney proximal tubular epithelial cells (PTECs) remains uncertain. In the current study, we analyzed the phenotype of newly generated PTEC-specific

Indexed as

AnimalsAutophagyCell MembraneEndocytosisEpithelial CellsErbB ReceptorsHumansIntracellular Signaling Peptides and ProteinsKidney Tubules, ProximalLipid MetabolismLipidomicsLysosomesMaleMiceMice, KnockoutMice, TransgenicErbB ReceptorsIntracellular Signaling Peptides and ProteinsPhospholipidsRubcn protein, mouseAutophagic fluxautophagylipid effluxlysosomemetabolic syndromeRUBCN/Rubicon

Identifiers

PMID31944172
PMCPMC8386605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.